Literature DB >> 12633994

Heparan sulfate proteoglycan as a plasma membrane carrier.

Mattias Belting1.   

Abstract

The plasma membrane defines the border of living cells and provides a barrier to extracellular components. Advances in molecular biology have resulted in the development of novel therapeutic strategies (e.g. gene therapy and cellular protein delivery) which rely on the entry of charged macromolecules into the intracellular compartment. Recent reports demonstrate an intriguing role for heparan sulfate proteoglycans in cellular internalization of viruses, basic peptides and polycation-nucleic-acid complexes and the possibility that they have important implications for gene transfer and protein delivery to mammalian cells. This review focuses on heparan sulfate proteoglycan as a plasma membrane carrier.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12633994     DOI: 10.1016/S0968-0004(03)00031-8

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  87 in total

1.  New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.

Authors:  J P M Langedijk; T Olijhoek; D Schut; R Autar; R H Meloen
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

2.  Magnetic nanoparticle-based isolation of endocytic vesicles reveals a role of the heat shock protein GRP75 in macromolecular delivery.

Authors:  Anders Wittrup; Si-He Zhang; Katrin J Svensson; Paulina Kucharzewska; Maria C Johansson; Matthias Mörgelin; Mattias Belting
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

Review 3.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

4.  Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

Authors:  Jennifer M MacArthur; Joseph R Bishop; Kristin I Stanford; Lianchun Wang; André Bensadoun; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 5.  Fine-tuning of cell signaling by glypicans.

Authors:  A Fico; F Maina; R Dono
Journal:  Cell Mol Life Sci       Date:  2011-02-22       Impact factor: 9.261

6.  Cellular binding, motion, and internalization of synthetic gene delivery polymers.

Authors:  Gaelen T Hess; William H Humphries; Nicole C Fay; Christine K Payne
Journal:  Biochim Biophys Acta       Date:  2007-08-07

7.  Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands.

Authors:  Christine K Payne; Sara A Jones; Chen Chen; Xiaowei Zhuang
Journal:  Traffic       Date:  2007-04       Impact factor: 6.215

Review 8.  Versatile role of heparanase in inflammation.

Authors:  Rachel Goldberg; Amichay Meirovitz; Nir Hirshoren; Raanan Bulvik; Adi Binder; Ariel M Rubinstein; Michael Elkin
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

9.  Structural characterization of the E2 domain of APL-1, a Caenorhabditis elegans homolog of human amyloid precursor protein, and its heparin binding site.

Authors:  James T Hoopes; Xuying Liu; Xiaomeng Xu; Borries Demeler; Ewa Folta-Stogniew; Chris Li; Ya Ha
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

10.  A new approach to glycan targeting: enzyme inhibition by oligosaccharide metalloshielding.

Authors:  John B Mangrum; Brigitte J Engelmann; Erica J Peterson; John J Ryan; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chem Commun (Camb)       Date:  2014-04-21       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.